Amphastar Nanjing Pharmaceuticals Inc., located in Nanjing Economic and Technological Development Zone, is a high-tech pharmaceutical company that is engaged in research and development, production and sales of active pharmaceutical ingredients and intermediates. It is a wholly owned subsidiary invested by Amphastar USA in February 2009.

We seek to be high-quality supplier of APIs under CGMP quality system. So far, we have submitted 8 DMF to FDA and are planning for registration of APIs in China, European Union and other countries. In the meantime, we will develop drug product for Chinese market.

© 2020 Amphastar Nanjing Pharmaceuticals Inc. All Rights Reserved.
Master marketing digital